z-logo
Premium
Philadelphia chromosome‐positive acute lymphoblastic leukemia secondary to chemoradiotherapy for Ewing sarcoma. Report of two cases and concise review of the literature
Author(s) -
Snyder David S.,
Stein Anthony S.,
O'Donnell Margaret R.,
Gaal Karl,
Slovak Marilyn L.,
Forman Stephen J.
Publication year - 2005
Publication title -
american journal of hematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.456
H-Index - 105
eISSN - 1096-8652
pISSN - 0361-8609
DOI - 10.1002/ajh.20251
Subject(s) - medicine , oncology , sarcoma , lymphoblastic leukemia , leukemia , radiation therapy , chemotherapy , chemoradiotherapy , population , pediatrics , pathology , environmental health
Survivors of childhood solid tumors including Ewing sarcoma (ES) have an increased risk of secondary malignant neoplasms (SMNs) as a consequence of exposure to chemotherapy and/or radiation (see: Bhatia S, Sklar C. Nat Rev Cancer 2002;2:124–132). The most common hematologic SMNs are myelodysplasia (MDS) and acute myelogenous leukemia (AML). Acute lymphoblastic leukemia (ALL) is uncommon in this patient population, and Philadelphia chromosome positive (Ph + ) ALL in particular, is rare. We report herein two cases of young adult patients who were both diagnosed with Ph + ALL 19 years after successful treatment for ES with combined modality therapy. A review of the relevant literature follows the case reports. Am. J. Hematol. 78:74–78, 2005. © 2004 Wiley‐Liss, Inc.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom